| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/22/2004 | WO2004007719A1 Use of sumo- and ubiquitin-modified pcna for detection and channeling of dna transaction pathways |
| 01/22/2004 | WO2004007718A2 Rna-interference by single-stranded rna molecules |
| 01/22/2004 | WO2004007716A1 Method of isolating gpcr gene and novel gpcr gene |
| 01/22/2004 | WO2004007715A1 Method of transferring mutation into target nucleic acid |
| 01/22/2004 | WO2004007712A2 Modulating developmental pathways in plants |
| 01/22/2004 | WO2004007711A1 Novel proteins and use thereof |
| 01/22/2004 | WO2004007709A2 Production of polyketides |
| 01/22/2004 | WO2004007702A2 Modulators of chloride intracellular channel 1 protein signaling ____________________________________________________________ |
| 01/22/2004 | WO2004007695A2 Lactobacilli expressing biologically active polypeptides and uses thereof |
| 01/22/2004 | WO2004007693A2 Human immunosuppressive protein |
| 01/22/2004 | WO2004007689A2 Regulatory protein for nox enzymes |
| 01/22/2004 | WO2004007687A2 Methods to construct multimeric dna and polymeric protein sequences as direct fusions or with linkers |
| 01/22/2004 | WO2004007685A2 Methods of modifying behavior of cd9-expressing cells |
| 01/22/2004 | WO2004007682A2 Methods and compositions for modulating t helper (th) cell development and function |
| 01/22/2004 | WO2004007679A2 Dendritic cell pontentiation |
| 01/22/2004 | WO2004007678A2 Codon optimized synthetic plasmids |
| 01/22/2004 | WO2004007675A2 Neuronal and optic nerve gene expression patterns |
| 01/22/2004 | WO2004007674A2 Neuronal and retinal gene expression patterns |
| 01/22/2004 | WO2004007673A2 Neuronal gene expression patterns |
| 01/22/2004 | WO2004007672A2 Methods and materials relating to novel polypeptides and polynucleotides |
| 01/22/2004 | WO2004007671A2 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A CLLD8 PROTEIN |
| 01/22/2004 | WO2004007669A2 Protein chips |
| 01/22/2004 | WO2004007668A2 Improved transporters and their uses |
| 01/22/2004 | WO2004007667A2 Polynucleotide and polypeptide fat metabolism regulators and uses thereof |
| 01/22/2004 | WO2004007666A2 Steroidogenic factor-1 protein variants and methods of making same |
| 01/22/2004 | WO2004007664A2 Nucleic acid vectors |
| 01/22/2004 | WO2004007663A2 Gene expression using metal ion dependent repressor/operator tandems |
| 01/22/2004 | WO2004007661A2 Carboxy protection strategies for acidic c-terminal amino acids in chemical ligation of oligopeptides |
| 01/22/2004 | WO2004007660A2 Novel hsf transcription factors and use thereof in transgenic plants |
| 01/22/2004 | WO2004007593A1 Poly-gamma-glutamate having ultra high molecular weight and method for using the same |
| 01/22/2004 | WO2004007557A2 Tf antagonist |
| 01/22/2004 | WO2004007552A1 Cytokine receptor |
| 01/22/2004 | WO2004007551A1 Splice variant cannabinoid receptor (cb1b) |
| 01/22/2004 | WO2004007549A1 Process for the purification of interleukin-4 and its muteins |
| 01/22/2004 | WO2004007547A2 Truncated tau proteins |
| 01/22/2004 | WO2004007546A1 Mutant proteins and use thereof for the manufacture of medicaments and the treatment of humans or animals suffering from conformational diseases |
| 01/22/2004 | WO2004007545A1 Method for inducing a conformational transition in proteins such as pathogenic/infectious proteins |
| 01/22/2004 | WO2004007544A2 Components of the presenilin-complex |
| 01/22/2004 | WO2004007543A1 Altered insulin-like growth factor binding proteins |
| 01/22/2004 | WO2004007542A1 Variants of the house dust mite allergen der f2 |
| 01/22/2004 | WO2004007541A1 STREPTOCOCCUS PNEUMONIAE PBP2x MINI-PROTEIN AND USES THEREOF. |
| 01/22/2004 | WO2004007540A1 Klebsiella membrane extracts exhibiting advantageous properties, and method for producing said extracts |
| 01/22/2004 | WO2004007539A2 Hsp70 from arthrobacter |
| 01/22/2004 | WO2004007538A2 Molecular antigen arrays using a virus like particle derived from the ap205 coat protein |
| 01/22/2004 | WO2004007537A2 Modified adenoviral fiber with ablated to cellular receptors |
| 01/22/2004 | WO2004007536A2 Interactions of the epstein-barr virus protein ebna1, and uses thereof |
| 01/22/2004 | WO2004007535A1 Bicyclic oligopeptides and their use as glucagon receptor antagonists |
| 01/22/2004 | WO2004007534A1 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A THIOREDOXIN-LIKE 32 kDA PROTEIN |
| 01/22/2004 | WO2004007533A1 Processes for the preparation of fibrinogen |
| 01/22/2004 | WO2004007532A2 Beta-sheet forming peptides and material made thereof |
| 01/22/2004 | WO2004007530A2 Modified proteins stabilized in a desired conformation and methods for producing same |
| 01/22/2004 | WO2004007528A2 Novel compositions and methods for the generation of mhc class ii compounds by peptide exchange |
| 01/22/2004 | WO2004007525A2 Immunogenic composition comprising a fusion protein and a saponin adjuvant |
| 01/22/2004 | WO2004007524A2 Bicyclic oligopeptides |
| 01/22/2004 | WO2004007069A1 Membrane, device and method for removing proteases from liquids |
| 01/22/2004 | WO2004006952A2 Therapeutic tuberculosis vaccines |
| 01/22/2004 | WO2004006951A1 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 01/22/2004 | WO2004006898A2 Use of compounds capable of inhibiting the proteolytic processing of semaphorins for prevention, treatment, diagnosis and prognosis of an invasive disease |
| 01/22/2004 | WO2004006866A2 Antifungal therapeutic targets |
| 01/22/2004 | WO2004006861A2 Peptides and methods of screening immunogenic peptide vaccines against alzheimer's disease |
| 01/22/2004 | WO2004006857A2 Glanders/meliodosis vaccines |
| 01/22/2004 | WO2004006848A2 Combination therapies with ftc for the treatment of hepatitis b virus infection |
| 01/22/2004 | WO2004006845A2 Process for producing insoluble and soluble collagen protein products from poultry skins and use thereof |
| 01/22/2004 | WO2004006843A2 Combination therapies with l-fmau for the treatment of hepatitis b virus infection |
| 01/22/2004 | WO2004006839A2 Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use |
| 01/22/2004 | WO2004006662A1 DISEASE MODEL ANIMAL CARRYING FOREIGN PPARα GENE TRANSFERRED THEREINTO AND USE THEREOF |
| 01/22/2004 | WO2004006655A2 Nuclear fertility restorer genes and methods of use in plants |
| 01/22/2004 | WO2003097665A3 Mid 241 receptor, a novel g-protein coupled receptor |
| 01/22/2004 | WO2003095640A3 Transgenic rat as animal model for human huntingdon's disease |
| 01/22/2004 | WO2003094858A3 Ctp-extended erythropoietin |
| 01/22/2004 | WO2003076603A3 Functionalization of t cell derived vesicles and use thereof for the preparation of immunogenic pharmaceutical compositions |
| 01/22/2004 | WO2003076561A3 Recombinase fusion protein with enhanced cellular uptake |
| 01/22/2004 | WO2003072800A3 Haemophilus adherence and penetration proteins |
| 01/22/2004 | WO2003072031A3 Treatment of disease by inducing cell apoptosis |
| 01/22/2004 | WO2003070759A3 Method of modulating e-cadherin mediated cell adhesion |
| 01/22/2004 | WO2003068966A3 REGULATION OF HUMAN Ca2+-PERMEABLE NONSELECTIVE CATION CHANNEL |
| 01/22/2004 | WO2003067213A3 Modulation of sulfate permease for photosynthetic hydrogen production |
| 01/22/2004 | WO2003066852A3 Plant growth modulation by drl1 and other proteins of the elongator complex |
| 01/22/2004 | WO2003066002A3 IFN-a/b-INDEPENDENT MECHANISM OF ANTIVIRAL PROTECTION |
| 01/22/2004 | WO2003059381A3 Immunogenic preparations and vaccines on the basis of mrna |
| 01/22/2004 | WO2003054213A3 Non-human primate fc receptors and methods of use |
| 01/22/2004 | WO2003054140A3 Phosphate limited inducible promoter and a bacillus expression system |
| 01/22/2004 | WO2003048205A3 Novel proteins with il-6 inhibiting activity |
| 01/22/2004 | WO2003044040A3 Alpha-fetoprotein peptides and uses thereof |
| 01/22/2004 | WO2003037919A3 Hiv-1 subtype isolate regulatory/accessory genes, and modifications and derivatives thereof |
| 01/22/2004 | WO2003029285A3 Identification of cd8 epitopes from hiv-1 proteins for prevention and therapy of hiv infections |
| 01/22/2004 | WO2003027251A3 Novel molecules of the pyrin domain protein family and uses thereof |
| 01/22/2004 | WO2003025121A3 Igf-binding protein-derived peptide or small molecule |
| 01/22/2004 | WO2003020889A3 Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules |
| 01/22/2004 | WO2003006497A3 Mutated photoproteins and their uses |
| 01/22/2004 | WO2003004701A3 Method for determining the capacity of fusarium in producing trichothecene toxins |
| 01/22/2004 | WO2003001883A3 Gaba b1a receptor disruptions, compositions and methods relating thereto |
| 01/22/2004 | WO2002099120A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/22/2004 | WO2002098917A3 Human proteins and nucleic acids encoding same |
| 01/22/2004 | WO2002092814A3 Screening method for attenuating or virulence defective microbial cells |
| 01/22/2004 | WO2002088339A3 Bursal disease virus-like particles |
| 01/22/2004 | WO2002078643A3 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 01/22/2004 | WO2002076389A3 Compositions and methods to prevent metastasis from primary malignancies |
| 01/22/2004 | WO2002069886A3 Modified proteins, designer toxins, and methods of making thereof |
| 01/22/2004 | WO2002065986A3 Transporters comprising spaced arginine moieties |